Marker Therapeutics (MRKR) Q3 2024 Earnings

Aug 14Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.43
-0.37
-0.31
-0.25

Details

Expected EPS
-0.4309
Actual EPS
-0.25
Surprise EPS
0.18
Surprise Percent
+41.98%

Description

⁨Marker Therapeutics⁩ (⁦MRKR⁩) has reported earnings of ⁦-0.25⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts